- $2.58bn
- $2.63bn
- $9.68m
Precigen Inc expected to post a loss of 10 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Arrowhead, Novavax, Precigen
Precigen up as rare viral disease therapy meets main goal in early-stage study
Precigen Inc expected to post a loss of 9 cents a share - Earnings Preview
Precigen Inc expected to post a loss of 9 cents a share - Earnings Preview
Precigen Inc reports results for the quarter ended in December - Earnings Summary
Precigen Inc expected to post a loss of 8 cents a share - Earnings Preview
Precigen Inc expected to post a loss of 8 cents a share - Earnings Preview
Newscasts - Brazil city deploys modified mosquitos to fight dengue surge
U.S. STOCKS ON THE MOVE-Halozyme, Scorpio Tankers
U.S. STOCKS ON THE MOVE-Halozyme, Scorpio Tankers, Advanced Micro Devices
U.S. STOCKS ON THE MOVE-InMode, Carrols Restaurant, Tesla
Precigen climbs on EU's 'orphan' tag for its respiratory tract disease treatment
Brief: Precigen Commercial Readiness Preparations Are Underway For A Potential US Launch In 2025
Brief: Precigen Pipeline Updates to be Presented at 42nd Annual J.P. Morgan Healthcare Conf
Brief: Precigen Files For Mixed Shelf Offering Of Up To $300 Million
Precigen Inc expected to post a loss of 8 cents a share - Earnings Preview
Precigen gains as Stifel raises PT on company's lead therapy prospects
U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Heritage Insurance, Mirati